23 Recruiting Depressive Disorder, Major Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Depressive Disorder, Major Studies
Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔bWell-D Pilot Randomized Controlled Trial
📍 UBC Centre for Brain Health — Vancouver, British Columbia
View Study & Checklist ➔Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation
📍 Mclean Hospital — Belmont, Massachusetts
View Study & Checklist ➔Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS
📍 Stanford Hospital — Stanford, California
View Study & Checklist ➔Psilocybin for Major Depressive Disorder (MDD)
📍 University of Alabama Clinical Research Unit — Birmingham, Alabama
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia
📍 Butler Hospital — Providence, Rhode Island
View Study & Checklist ➔A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
📍 University of Alabama at Birmingham - School of Medicine — Birmingham, Alabama
View Study & Checklist ➔A Study of Brenipatide in Adult Participants With Major Depressive Disorder
📍 Accellacare - Moorpark — Moorpark, California
View Study & Checklist ➔Biomarkers of Depression and Treatment Response
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
📍 Yale University — New Haven, Connecticut
View Study & Checklist ➔A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
📍 SanRo Clinical Research Group LLC WCG Clinical Network — Bryant, Arkansas
View Study & Checklist ➔A Study of Lumateperone Versus Placebo in Participants With Major Depressive Disorder
📍 Clinical Research Facility — ,
View Study & Checklist ➔